Mean Micronuclei Score in Fine-Needle Aspiration Cytology of Patients with Malignant Breast Lump in the Department of Pathology in a Tertiary Care Centre: A Descriptive Cross-sectional Study
- PMID: 36705103
- PMCID: PMC9795124
- DOI: 10.31729/jnma.7909
Mean Micronuclei Score in Fine-Needle Aspiration Cytology of Patients with Malignant Breast Lump in the Department of Pathology in a Tertiary Care Centre: A Descriptive Cross-sectional Study
Abstract
Introduction: Micronucleus is used as a biomarker of chromosomal instability, which is one of the hallmarks of neoplastic transformation. As micronuclei score increases with malignancy, it can be an effective and inexpensive adjunct to breast fine needle aspiration cytology, in diagnosing breast lumps, especially detecting grey lesions between benign and malignant tumours. The aim of this study is to find out the mean micronuclei score in fine-needle aspiration cytology of patients with malignant breast lumps in the Department of Pathology in a tertiary care centre.
Methods: A descriptive cross-sectional study was conducted among patients with malignant breast lumps in the Department of Pathology in a tertiary care centre between 1 May 2020 to 31 May 2021 after receiving ethical approval from the Institutional Review Committee (Reference number: IRC/2139/021). The fine-needle aspiration cytology of breast lumps was diagnosed as per National Health services breast screening program guidelines. The mean micronuclei score was calculated. Convenience sampling was done and data were collected from the hospital records in the Department. Point estimate and 95% Confidence Interval were calculated.
Results: Among 20 malignant breast aspirates, the mean micronuclei score was found to be 8.30±3.75 (3-19, 95% Confidence Interval).
Conclusions: The mean micronuclei score in fine-needle aspiration cytology of malignant breast lumps was found to be similar when compared to similar studies conducted in similar settings.
Keywords: biomarker; breast neoplasm; chromosomal instability; fine-needle aspiration.
Conflict of interest statement
Similar articles
-
Thyroid Malignancy among Fine Needle Aspiration Cytology of Thyroid Lesions in a Tertiary Care Centre.JNMA J Nepal Med Assoc. 2024 Jan 2;62(269):21-23. doi: 10.31729/jnma.8396. JNMA J Nepal Med Assoc. 2024. PMID: 38410013 Free PMC article.
-
Comparative Study of Core Needle Biopsy and Fine Needle Aspiration Cytology in Palpable Breast Lumps: Scenario in Developing Nations.Turk Patoloji Derg. 2016;32(1):1-7. doi: 10.5146/tjpath.2015.01335. Turk Patoloji Derg. 2016. PMID: 26832175 Clinical Trial.
-
Fine needle aspiration cytology of breast lumps with histopathologic correlation in Owo, Ondo State, Nigeria: a five-year review.Ghana Med J. 2017 Mar;51(1):1-5. doi: 10.4314/gmj.v51i1.1. Ghana Med J. 2017. PMID: 28959065 Free PMC article.
-
Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy in Diagnosing Breast Cancer.Acta Cytol. 2023;67(1):1-16. doi: 10.1159/000527346. Epub 2022 Nov 22. Acta Cytol. 2023. PMID: 36412573
-
International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology: A Review of Predictive Values and Risks of Malignancy.Acta Cytol. 2019;63(4):292-301. doi: 10.1159/000500704. Epub 2019 May 29. Acta Cytol. 2019. PMID: 31141809
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials